Equity Capital Markets

Company · CIK 1737287

Allogene Therapeutics, Inc.

CIK1737287 (SEC EDGAR)
Industry (SIC)2836 — Biological Products, (No Diagnostic Substances)
Business addressCA
ListedALLO (Nasdaq)
First annual or quarterly report2018-11-21

Offerings

5 registrations
RegistrationLabel and statusFirst filedLast eventFilings
333-298268
ShelfEffective
 2026-08-122026-08-202
333-277951
ShelfEffective
 2024-03-142026-06-226
333-268117
ShelfEffective
 2022-11-022023-11-022
333-234516
ShelfEffective
 2019-11-052020-06-033
333-227333
IPOFinal prospectus
 2018-09-142018-10-116

Filings

20
FiledFilingRegistrationAccession
2026-08-20EFFECTDeclared effective 333-2982689999999995-26-002725
2026-08-12S-3Shelf registered 333-2982680001628280-26-056232
2026-06-22424B5Shelf takedown 333-2779510001628280-26-044616
2026-04-15424B5Shelf takedown 333-2779510001193125-26-157128
2026-04-13424B5Shelf takedown 333-2779510001193125-26-152989
2024-05-14424B5Shelf takedown 333-2779510001193125-24-138311
2024-04-25EFFECTDeclared effective 333-2779519999999995-24-001124
2024-03-14S-3Shelf registered 333-2779510001193125-24-068041
2023-11-02424B5Shelf takedown 333-2681170001193125-23-269437
2022-11-02S-3ASRShelf registered 333-2681170001737287-22-000085
2020-06-03424B5Shelf takedown 333-2345160001737287-20-000036
2020-06-01424B5Shelf takedown 333-2345160001737287-20-000032
2019-11-05S-3ASRShelf registered 333-2345160001737287-19-000022
2018-10-11424B4Final prospectus 333-2273330001193125-18-297747
2018-10-10EFFECTDeclared effective 333-2273339999999995-18-002586
2018-10-05S-1/AAmendment 333-2273330001193125-18-294771
2018-10-02S-1/AAmendment 333-2273330001193125-18-290441
2018-09-17S-1/AAmendment 333-2273330001193125-18-275199
2018-09-14S-1Registration filed 333-2273330001193125-18-273504
2018-08-10DRSDraft made public 377-022110000950123-18-008039

All filings of this company · CSV